News

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...
In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that ...